Cargando…
_version_ 1784899319181082624
author Suñer, Clara
Ubals, Maria
Tarín-Vicente, Eloy José
Mendoza, Adrià
Alemany, Andrea
Hernández-Rodríguez, Águeda
Casañ, Cristina
Descalzo, Vicente
Ouchi, Dan
Marc, Aurélien
Rivero, Àngel
Coll, Pep
Oller, Xènia
Miguel Cabrera, José
Vall-Mayans, Martí
Dolores Folgueira, María
Ángeles Melendez, María
Agud-Dios, Manuel
Gil-Cruz, Elena
Paris de Leon, Alexia
Ramírez Marinero, Aída
Buhiichyk, Vira
Galván-Casas, Cristina
Paredes, Roger
Prat, Nuria
Sala Farre, Maria-Rosa
Bonet-Simó, Josep Maria
Farré, Magí
Ortiz-Romero, Pablo L
Clotet, Bonaventura
García-Patos, Vicente
Casabona, Jordi
Guedj, Jeremie
Cardona, Pere-Joan
Blanco, Ignacio
Marks, Michael
Mitjà, Oriol
author_facet Suñer, Clara
Ubals, Maria
Tarín-Vicente, Eloy José
Mendoza, Adrià
Alemany, Andrea
Hernández-Rodríguez, Águeda
Casañ, Cristina
Descalzo, Vicente
Ouchi, Dan
Marc, Aurélien
Rivero, Àngel
Coll, Pep
Oller, Xènia
Miguel Cabrera, José
Vall-Mayans, Martí
Dolores Folgueira, María
Ángeles Melendez, María
Agud-Dios, Manuel
Gil-Cruz, Elena
Paris de Leon, Alexia
Ramírez Marinero, Aída
Buhiichyk, Vira
Galván-Casas, Cristina
Paredes, Roger
Prat, Nuria
Sala Farre, Maria-Rosa
Bonet-Simó, Josep Maria
Farré, Magí
Ortiz-Romero, Pablo L
Clotet, Bonaventura
García-Patos, Vicente
Casabona, Jordi
Guedj, Jeremie
Cardona, Pere-Joan
Blanco, Ignacio
Marks, Michael
Mitjà, Oriol
author_sort Suñer, Clara
collection PubMed
description BACKGROUND: Monkeypox DNA has been detected in skin lesions, saliva, oropharynx, urine, semen, and stool of patients infected during the 2022 clade IIb outbreak; however, the viral dynamics within these compartments remain unknown. We aimed to characterise the viral load kinetics over time in various parts of the body. METHODS: This was an observational, prospective, multicentre study of outpatients diagnosed with monkeypox in two hospitals and two sexual health clinics in Spain between June 28, 2022, and Sept 22, 2022. Men and women aged over 18 years were eligible if they reported having symptom onset within the previous 10 days of presentation, and were ineligible if disease was severe enough to be admitted to hospital. Samples were collected from five body locations (skin lesions, oropharynx, rectum, semen or vagina, and a dried blood spot) at six time points up to 57 days after the screening visit. Samples were analysed by quantitative PCR and a subset by cell culture. The primary endpoint was time from symptom onset to viral DNA clearance. FINDINGS: Overall, 1663 samples were collected from 77 study participants. 75 (97%) participants were men, the median age was 35·0 years (IQR 29·0–46·0), and 39 (51%) participants were living with HIV. The median time from symptom onset to viral clearance was 25 days (95% CI 23–28) in the skin lesions, 16 days (13–19) in the oropharynx, 16 days (13–23) in the rectum, 13 days in semen (9–18), and 1 day in blood (0–5). The time from symptom onset to viral clearance for 90% of cases was 41 days (95% CI 34–47) in skin lesions and 39 days (27–56) in semen. The median viral load in skin lesions was 7·3 log(10) copies per mL (IQR 6·5–8·2) at baseline, compared with 4·6 log(10) copies per mL (2·9–5·8) in oropharyngeal samples, 5·0 log(10) copies per mL (2·9–7·5) in rectal samples, 3·5 log(10) copies per mL (2·9–4·7) in semen samples, and 4·0 log(10) copies per mL (4·0–4·0) in blood specimens. Replication-competent viruses were isolated in samples with high DNA levels (>6·5 log(10) copies per mL). INTERPRETATION: In immunocompetent patients with mild monkeypox disease, PCR data alone would suggest a contact isolation period of 3 to 6 weeks but, based on detection of replication-competent virus, this time could be reduced. Based on findings from this cohort of patients, semen testing and prolonged use of condoms after recovery from monkeypox might not be necessary. FUNDING: University Hospital Germans Trias i Pujol and the YoMeCorono. TRANSLATION: For the Spanish translation of the abstract see Supplementary Materials section.
format Online
Article
Text
id pubmed-9977560
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-99775602023-03-02 Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain Suñer, Clara Ubals, Maria Tarín-Vicente, Eloy José Mendoza, Adrià Alemany, Andrea Hernández-Rodríguez, Águeda Casañ, Cristina Descalzo, Vicente Ouchi, Dan Marc, Aurélien Rivero, Àngel Coll, Pep Oller, Xènia Miguel Cabrera, José Vall-Mayans, Martí Dolores Folgueira, María Ángeles Melendez, María Agud-Dios, Manuel Gil-Cruz, Elena Paris de Leon, Alexia Ramírez Marinero, Aída Buhiichyk, Vira Galván-Casas, Cristina Paredes, Roger Prat, Nuria Sala Farre, Maria-Rosa Bonet-Simó, Josep Maria Farré, Magí Ortiz-Romero, Pablo L Clotet, Bonaventura García-Patos, Vicente Casabona, Jordi Guedj, Jeremie Cardona, Pere-Joan Blanco, Ignacio Marks, Michael Mitjà, Oriol Lancet Infect Dis Articles BACKGROUND: Monkeypox DNA has been detected in skin lesions, saliva, oropharynx, urine, semen, and stool of patients infected during the 2022 clade IIb outbreak; however, the viral dynamics within these compartments remain unknown. We aimed to characterise the viral load kinetics over time in various parts of the body. METHODS: This was an observational, prospective, multicentre study of outpatients diagnosed with monkeypox in two hospitals and two sexual health clinics in Spain between June 28, 2022, and Sept 22, 2022. Men and women aged over 18 years were eligible if they reported having symptom onset within the previous 10 days of presentation, and were ineligible if disease was severe enough to be admitted to hospital. Samples were collected from five body locations (skin lesions, oropharynx, rectum, semen or vagina, and a dried blood spot) at six time points up to 57 days after the screening visit. Samples were analysed by quantitative PCR and a subset by cell culture. The primary endpoint was time from symptom onset to viral DNA clearance. FINDINGS: Overall, 1663 samples were collected from 77 study participants. 75 (97%) participants were men, the median age was 35·0 years (IQR 29·0–46·0), and 39 (51%) participants were living with HIV. The median time from symptom onset to viral clearance was 25 days (95% CI 23–28) in the skin lesions, 16 days (13–19) in the oropharynx, 16 days (13–23) in the rectum, 13 days in semen (9–18), and 1 day in blood (0–5). The time from symptom onset to viral clearance for 90% of cases was 41 days (95% CI 34–47) in skin lesions and 39 days (27–56) in semen. The median viral load in skin lesions was 7·3 log(10) copies per mL (IQR 6·5–8·2) at baseline, compared with 4·6 log(10) copies per mL (2·9–5·8) in oropharyngeal samples, 5·0 log(10) copies per mL (2·9–7·5) in rectal samples, 3·5 log(10) copies per mL (2·9–4·7) in semen samples, and 4·0 log(10) copies per mL (4·0–4·0) in blood specimens. Replication-competent viruses were isolated in samples with high DNA levels (>6·5 log(10) copies per mL). INTERPRETATION: In immunocompetent patients with mild monkeypox disease, PCR data alone would suggest a contact isolation period of 3 to 6 weeks but, based on detection of replication-competent virus, this time could be reduced. Based on findings from this cohort of patients, semen testing and prolonged use of condoms after recovery from monkeypox might not be necessary. FUNDING: University Hospital Germans Trias i Pujol and the YoMeCorono. TRANSLATION: For the Spanish translation of the abstract see Supplementary Materials section. Elsevier Ltd. 2023-04 2022-12-12 /pmc/articles/PMC9977560/ /pubmed/36521505 http://dx.doi.org/10.1016/S1473-3099(22)00794-0 Text en © 2022 Elsevier Ltd. All rights reserved. Elsevier has created a Monkeypox Information Center (https://www.elsevier.com/connect/monkeypox-information-center) in response to the declared public health emergency of international concern, with free information in English on the monkeypox virus. The Monkeypox Information Center is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its monkeypox related research that is available on the Monkeypox Information Center - including this research content - immediately available in publicly funded repositories, with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the Monkeypox Information Center remains active.
spellingShingle Articles
Suñer, Clara
Ubals, Maria
Tarín-Vicente, Eloy José
Mendoza, Adrià
Alemany, Andrea
Hernández-Rodríguez, Águeda
Casañ, Cristina
Descalzo, Vicente
Ouchi, Dan
Marc, Aurélien
Rivero, Àngel
Coll, Pep
Oller, Xènia
Miguel Cabrera, José
Vall-Mayans, Martí
Dolores Folgueira, María
Ángeles Melendez, María
Agud-Dios, Manuel
Gil-Cruz, Elena
Paris de Leon, Alexia
Ramírez Marinero, Aída
Buhiichyk, Vira
Galván-Casas, Cristina
Paredes, Roger
Prat, Nuria
Sala Farre, Maria-Rosa
Bonet-Simó, Josep Maria
Farré, Magí
Ortiz-Romero, Pablo L
Clotet, Bonaventura
García-Patos, Vicente
Casabona, Jordi
Guedj, Jeremie
Cardona, Pere-Joan
Blanco, Ignacio
Marks, Michael
Mitjà, Oriol
Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain
title Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain
title_full Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain
title_fullStr Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain
title_full_unstemmed Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain
title_short Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain
title_sort viral dynamics in patients with monkeypox infection: a prospective cohort study in spain
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977560/
https://www.ncbi.nlm.nih.gov/pubmed/36521505
http://dx.doi.org/10.1016/S1473-3099(22)00794-0
work_keys_str_mv AT sunerclara viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT ubalsmaria viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT tarinvicenteeloyjose viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT mendozaadria viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT alemanyandrea viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT hernandezrodriguezagueda viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT casancristina viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT descalzovicente viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT ouchidan viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT marcaurelien viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT riveroangel viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT collpep viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT ollerxenia viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT miguelcabrerajose viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT vallmayansmarti viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT doloresfolgueiramaria viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT angelesmelendezmaria viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT aguddiosmanuel viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT gilcruzelena viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT parisdeleonalexia viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT ramirezmarineroaida viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT buhiichykvira viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT galvancasascristina viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT paredesroger viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT pratnuria viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT salafarremariarosa viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT bonetsimojosepmaria viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT farremagi viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT ortizromeropablol viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT clotetbonaventura viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT garciapatosvicente viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT casabonajordi viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT guedjjeremie viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT cardonaperejoan viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT blancoignacio viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT marksmichael viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain
AT mitjaoriol viraldynamicsinpatientswithmonkeypoxinfectionaprospectivecohortstudyinspain